DOCSLIB.ORG

Federal Register/Vol. 76, No. 22/Wednesday, February 2, 2011

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Federal Register/Vol. 76, No. 22/Wednesday, February 2, 2011 5830 Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Notices investigated Cambridge Isotope Lab to Drug Schedule Drug Schedule ensure that the company’s registration is consistent with the public interest. The Oripavine (9330) ........................... II Secobarbital (2315) ...................... II investigation has included inspection Thebaine (9333) ........................... II Phenylacetone (8501) .................. II and testing of the company’s physical Oxymorphone (9652) ................... II Cocaine (9041) ............................. II Codeine (9050) ............................. II security systems, verification of the Phenazocine (9715) ..................... II Fentanyl (9801) ............................ II Dihydrocodeine (9120) ................. II company’s compliance with state and Oxycodone (9143) ........................ II local laws, and a review of the The company plans to manufacture Hydromorphone (9150) ................ II company’s background and history. small quantities of the listed controlled Diphenoxylate (9170) ................... II Ecgonine (9180) ........................... II Therefore, pursuant to 21 U.S.C. 823(a), substances as radiolabeled compounds and in accordance with 21 CFR 1301.33, Hydrocodone (9193) ..................... II for biochemical research. Meperidine (9230) ........................ II the above named company is granted No comments or objections have been registration as a bulk manufacturer of Methadone (9250) ........................ II received. DEA has considered the Morphine (9300) ........................... II the basic class of controlled substance factors in 21 U.S.C. 823(a) and Oxymorphone (9652) ................... II listed. determined that the registration of Alfentanil (9737) ........................... II Dated: January 18, 2011. American Radiolabeled Chemicals, Inc. Remifentanil (9739) ...................... II Sufentanil (9740) .......................... II Joseph T. Rannazzisi, to manufacture the listed basic classes Fentanyl (9801) ............................ II Deputy Assistant Administrator, Office of of controlled substances is consistent Diversion Control, Drug Enforcement with the public interest at this time. The company plans on manufacturing Administration. DEA has investigated American the listed controlled substances in bulk [FR Doc. 2011–2295 Filed 2–1–11; 8:45 am] Radiolabeled Chemicals Inc. to ensure for sale to its customers. BILLING CODE 4410–09–P that the company’s registration is No comments or objections have been consistent with the public interest. The received. DEA has considered the investigation has included inspection factors in 21 U.S.C. 823(a) and DEPARTMENT OF JUSTICE and testing of the company’s physical determined that the registration of Cody security systems, verification of the Drug Enforcement Administration Laboratories to manufacture the listed company’s compliance with state and basic classes of controlled substances is Manufacturer of Controlled local laws, and a review of the consistent with the public interest at Substances; Notice of Registration company’s background and history. this time. DEA has investigated Cody Therefore, pursuant to 21 U.S.C. 823(a), Laboratories to ensure that the By Notice dated August 3, 2010, and and in accordance with 21 CFR 1301.33, company’s registration is consistent published in the Federal Register on the above named company is granted with the public interest. The September 1, 2010, (75 FR 53720), registration as a bulk manufacturer of investigation has included inspection American Radiolabeled Chemicals, Inc., the basic classes of controlled and testing of the company’s physical 101 Arc Drive, St. Louis, Missouri substances listed. security systems, verification of the 63146, made application by renewal to Dated: January 18, 2011. company’s compliance with state and the Drug Enforcement Administration Joseph T. Rannazzisi, local laws, and a review of the (DEA) to be registered as a bulk Deputy Assistant Administrator, Office of company’s background and history. manufacturer of the following basic Diversion Control, Drug Enforcement Therefore, pursuant to 21 U.S.C. 823(a), classes of controlled substances: Administration. and in accordance with 21 CFR 1301.33, the above named company is granted Drug Schedule [FR Doc. 2011–2294 Filed 2–1–11; 8:45 am] BILLING CODE 4410–09–P registration as a bulk manufacturer of Gamma Hydroxybutyric Acid I the basic classes of controlled (2010). substances listed. Ibogaine (7260) ............................ I DEPARTMENT OF JUSTICE Dated: January 18, 2011. Lysergic acid diethylamide (7315) I Joseph T. Rannazzisi, Tetrahydrocannabinols (7370) ..... I Drug Enforcement Administration Dimethyltryptamine (7435) ........... I Deputy Assistant Administrator, Office of 1-[1-(2- I Manufacturer of Controlled Diversion Control, Drug Enforcement Thienyl)cyclohexyl]piperidine Substances; Notice of Registration Administration. (7470). [FR Doc. 2011–2291 Filed 2–1–11; 8:45 am] Dihydromorphine (9145) ............... I By Notice dated August 2, 2010, and BILLING CODE 4410–09–P Normorphine (9313) ..................... I published in the Federal Register on Amphetamine (1100) .................... II September 1, 2010, 75 FR 53720, Cody Methamphetamine (1105) ............ II Laboratories, 601 Yellowstone Avenue, DEPARTMENT OF JUSTICE Amobarbital (2125) ....................... II Cody, Wyoming 82414, made Phencyclidine (7471) .................... II Federal Bureau of Investigation Phenylacetone (8501) .................. II application by renewal to the Drug Cocaine (9041) ............................. II Enforcement Administration (DEA) to [Docket No. FBI 150] Codeine (9050) ............................. II be registered as a bulk manufacturer of Dihydrocodeine (9120) ................. II the following basic classes of controlled FBI Records Management Division; Oxycodone (9143) ........................ II substances: National Name Check Program Hydromorphone (9150) ................ II Section; New User Fees Schedule Ecgonine (9180) ........................... II Drug Schedule Hydrocodone (9193) ..................... II AGENCY: Federal Bureau of Investigation Meperidine (9230) ........................ II Dihydromorphine (9145) ............... I (FBI), Justice. Metazocine (9240) ........................ II Amphetamine (1100) .................... II ACTION: Notice. Dextropropoxyphene, bulk (non- II Methamphetamine (1105) ............ II dosage forms) (9273). Amobarbital (2125) ....................... II SUMMARY: Pursuant to 28 CFR Morphine (9300) ........................... II Pentobarbital (2270) ..................... II 20.31(e)(3), this notice establishes a new VerDate Mar<15>2010 16:00 Feb 01, 2011 Jkt 223001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\02FEN1.SGM 02FEN1 srobinson on DSKHWCL6B1PROD with NOTICES.
Load more

Recommended publications
  • SENATE BILL No. 52
    As Amended by Senate Committee Session of 2017 SENATE BILL No. 52 By Committee on Public Health and Welfare 1-20 1 AN ACT concerning the uniform controlled substances act; relating to 2 substances included in schedules I, II and V; amending K.S.A. 2016 3 Supp. 65-4105, 65-4107 and 65-4113 and repealing the existing 4 sections. 5 6 Be it enacted by the Legislature of the State of Kansas: 7 Section 1. K.S.A. 2016 Supp. 65-4105 is hereby amended to read as 8 follows: 65-4105. (a) The controlled substances listed in this section are 9 included in schedule I and the number set forth opposite each drug or 10 substance is the DEA controlled substances code which has been assigned 11 to it. 12 (b) Any of the following opiates, including their isomers, esters, 13 ethers, salts, and salts of isomers, esters and ethers, unless specifically 14 excepted, whenever the existence of these isomers, esters, ethers and salts 15 is possible within the specific chemical designation: 16 (1) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)- 17 N-phenylacetamide)......................................................................9821 18 (2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4- 19 piperidinyl]-N-phenylacetamide)..................................................9815 20 (3) Acetylmethadol.............................................................................9601 21 (4) AH-7921 (3.4-dichloro-N-[(1- 22 dimethylaminocyclohexylmethyl]benzamide)...............................9551 23 (4)(5) Allylprodine...........................................................................9602
    [Show full text]
  • Demonstration and Affinity Labeling of a Stereoselective Binding Site for A
    Proc. Nati. Acad. Sci. USA Vol. 82, pp. 940-944, February 1985 Neurobiology Demonstration and affinity labeling of a stereoselective binding site for a benzomorphan opiate on acetylcholine receptor-rich membranes from Torpedo electroplaque (cholinergic receptor/ion channel/photoaffinity labeling/N-aliyl-N-normetazocine/phencyclidine) ROBERT E. OSWALD, NANCY N. PENNOW, AND JAMES T. MCLAUGHLIN Department of Pharmacology, New York State College of Veterinary Medicine, Cornell University, Ithaca, NY 14853 Communicated by R. H. Wasserman, October 3, 1984 ABSTRACT The interaction of an optically pure benzo- Benzomorphan opiates have been shown to inhibit the morphan opiate, (-)-N-allyl-N-normetazocine [(-)-ANMC], binding of [3H]PCP to central nervous system synaptic mem- with the nicotinic acetylcholine receptor from Torpedo electro- branes (15, 16) and to modify the activity of serum cholines plaque was studied by using radioligand binding and affinity terase (17). Some opiate derivatives, in particular the benzo- labeling. The binding was complex with at least two specific morphans, can inhibit the binding of [3H]perhydrohistrioni- components having equilibrium dissociation constants of 0.3 cotoxin and [3H]PCP to the Torpedo AcChoR (18, 19). In the jiM and 2 jiM. The affinity of the higher affinity component present studies, a radioactive optically pure benzomorphan, was decreased by carbamoylcholine but not by a-bungaro- (-)-[3H]N-allyl-N-normetazocine {(-)-[3H]ANMC}, was toxin. The effect of carbamoylcholine was not blocked by a- used to measure reversible binding to and affinity labeling of bungarotoxin. In comparison, the affinity of [3Hlphencycli- the Torpedo electroplaque AcChoR. Specific binding was dine, a well-characterized ligand for a high-affinity site for shown to be complex with at least one component having noncompetitive blockers on the acetylcholine receptor, is in- lower affinity in the presence rather than the absence of cho- creased by carbamoylcholine and the increase is blocked by a- linergic effectors.
    [Show full text]
  • Drugs of Abuseon September Archived 13-10048 No
    U.S. DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION WWW.DEA.GOV 9, 2014 on September archived 13-10048 No. v. Stewart, in U.S. cited Drugs of2011 Abuse EDITION A DEA RESOURCE GUIDE V. Narcotics WHAT ARE NARCOTICS? Also known as “opioids,” the term "narcotic" comes from the Greek word for “stupor” and originally referred to a variety of substances that dulled the senses and relieved pain. Though some people still refer to all drugs as “narcot- ics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, morphine, methadone and fentanyl. WHAT IS THEIR ORIGIN? The poppy papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine cabinets, pharmacies, nursing 2014 homes, hospitals, hospices, doctors, and the Internet. 9, on September archived 13-10048 No. v. Stewart, in U.S. cited What are common street names? Street names for various narcotics/opioids include: ➔ Hillbilly Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton, Sippin Syrup What are their forms? Narcotics/opioids come in various forms including: ➔ T ablets, capsules, skin patches, powder, chunks in varying colors (from white to shades of brown and black), liquid form for oral use and injection, syrups, suppositories, lollipops How are they abused? ➔ Narcotics/opioids can be swallowed, smoked, sniffed, or injected.
    [Show full text]
  • Outline for Controlled Substances Program
    Environmental Health and Safety Controlled Substances Program Date of Issuance: Review Date: 10/1/2019 (no changes) 10/01/2018 Revision Number: Initial Prepared by: EH&S Table of Contents HEADINGS Introduction Applicability Responsibilities Registration Requirements Authorized Use Ordering/Purchasing Administering and Dispensing Inventory Procedures (Continuing Records) Security Disposal FORMS: Registering or renewing a DEA or state license (CMU) Controlled Substances Authorized users list (CMU) Employee questionnaire for those with access to controlled substances (CMU) Record of Form 222 use (Order form) (CMU) Records of Controlled Substance Purchases (CMU) Record of Controlled Substance Administering and dispensing (CMU) Controlled Substance Physical Inventory (CMU) DEA Registration of Persons doing research or analysis (Form 225) DEA Registration of Dispensers (Form 224) DEA Registration Instructional (Form 224 and 226 to renew) DEA Report of loss or theft (Form 106) DEA Report of drugs surrendered (From 41) DEA SCHEDULES: Schedule I Schedule II Schedule III Schedule IV Schedule V INTRODUCTION State and Federal regulations have been promulgated concerning the use and handling of US Department of Justice Drug Enforcement Administration (DEA) controlled substances. These regulations are in place to address materials which are or have the potential to be addictive or habit forming. These substances have been categorized into “schedules” that have been created by the DEA to reflect their level of concern. The “Carnegie Mellon University DEA Controlled Substances Program” is intended to ensure that Carnegie Mellon University is in compliance with our regulatory requirements. Required activities under the DEA include: 1. Registration of your work with the DEA and with Carnegie Mellon’s Department of Environmental Health and Safety (EH&S).
    [Show full text]
  • Recreational Marijuana Legalization and Prescription Opioids Received by Medicaid Enrollees T ⁎ Yuyan Shia, , Di Lianga, Yuhua Baob, Ruopeng Anc, Mark S
    Drug and Alcohol Dependence 194 (2019) 13–19 Contents lists available at ScienceDirect Drug and Alcohol Dependence journal homepage: www.elsevier.com/locate/drugalcdep Full length article Recreational marijuana legalization and prescription opioids received by Medicaid enrollees T ⁎ Yuyan Shia, , Di Lianga, Yuhua Baob, Ruopeng Anc, Mark S. Wallaced, Igor Grante a Department of Family Medicine and Public Health, University of California San Diego, 9500 Gilman Dr, La Jolla, CA, 92093, USA b Department of Healthcare Policy and Research, Weill Cornell Medical College, 425 E 61stSt., New York, NY, 10065, USA c Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, 1206 S 4thSt, Champaign, IL, 61820, USA d Department of Anesthesiology, University of California San Diego, 9500 Gilman Dr, La Jolla, CA, 92093, USA e Department of Psychiatry, University of California San Diego, 9500 Gilman Dr, La Jolla, CA, 92093, USA ARTICLE INFO ABSTRACT Keywords: Objectives: Medical marijuana use may substitute prescription opioid use, whereas nonmedical marijuana use Marijuana may be a risk factor of prescription opioid misuse. This study examined the associations between recreational Opioid marijuana legalization and prescription opioids received by Medicaid enrollees. Recreational marijuana legalization Methods: State-level quarterly prescription drug utilization records for Medicaid enrollees during 2010–2017 Opioid prescription were obtained from Medicaid State Drug Utilization Data. The primary outcome, opioid prescriptions received, Medicaid was measured in three population-adjusted variables: number of opioid prescriptions, total doses of opioid prescriptions in morphine milligram equivalents, and related Medicaid spending, per quarter per 100 enrollees. Two difference-in-difference models were used to test the associations: eight states and DC that legalized re- creational marijuana during the study period were first compared among themselves, then compared to six states with medical marijuana legalized before the study period.
    [Show full text]
  • 19 CSR 30-1.042 Inventory Requirements
    Rules of Department of Health and Senior Services Division 30—Division of Regulation and Licensure Chapter 1—Controlled Substances Title Page 19 CSR 30-1.002 Schedules of Controlled Substances .........................................................3 19 CSR 30-1.004 List of Excepted Substances.................................................................13 19 CSR 30-1.006 List of Exempt Anabolic Steroid Products................................................13 19 CSR 30-1.008 List of Excluded Veterinary Anabolic Steroid Implant Products......................14 19 CSR 30-1.010 Schedules of Controlled Substances (Rescinded November 30, 2000)...............14 19 CSR 30-1.011 Definitions......................................................................................15 19 CSR 30-1.013 Miscellaneous Fees ...........................................................................16 19 CSR 30-1.015 Registrations and Fees........................................................................16 19 CSR 30-1.017 Registration Process ..........................................................................16 19 CSR 30-1.019 Registration Location.........................................................................19 19 CSR 30-1.020 List of Excepted Substances (Rescinded November 30, 2000)........................19 19 CSR 30-1.023 Registration Changes .........................................................................19 19 CSR 30-1.025 List of Exempt Anabolic Steroid Products (Rescinded November 30, 2000).......20 19 CSR 30-1.026
    [Show full text]
  • Tennessee Drug Statutes (Listed in Numerical Order)
    Tennessee Drug Statutes (listed in numerical order) 39-17-405. Criteria for Schedule I. • The commissioner of mental health and substance abuse services, upon the agreement of the commissioner of health, shall place a substance in Schedule I upon finding that the substance has: o (1) High potential for abuse; and o (2) No accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision. 39-17-406. Controlled substances in Schedule I. • (a) Schedule I consists of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. • (b) Opiates, unless specifically excepted or unless listed in another schedule, means any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation. For the purposes of subdivision (b)(34) only, the term isomer includes the optical and geometric isomers. o (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4- piperidinyl]-N-phenylacetamide); o (2) Acetylmethadol; o (3) Allylprodine; o (4) Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol; levomethadyl acetate; or LAAM); o (5) Alphameprodine; o (6) Alphamethadol; o (7) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4- piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- propanilido)piperidine;
    [Show full text]
  • New Drug Substances with Abuse Potential
    New drug substances with abuse potential: Points to consider for the development and marketing - Regulatory environment in the European Union and the United States - Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels „Master of Drug Regulatory Affairs“ der Mathematisch-Naturwissenschaftlichen Falkultät der Rheinischen Friedrich-Wilhems-Universität Bonn vorgelegt von Dr. Silke Jung Bonn 2006 Betreuer und 1. Referent: Dr. Winfried Kleinert, Bundesopiumstelle (BfArM) Zweiter Referent: RA Burkhard Stäter, Anwaltskanzlei Sträter To my husband - for his patience and support - Danksagung An erster Stelle möchte ich mich ganz herzlich bei Herrn Dr. Winfried Kleinert und Herrn RA Burkhard Sträter für die Betreuung und Unterstützung meiner Arbeit bedanken. Mein besonderer Dank gilt auch Herrn Dr. Joachim Heinze und Herrn Dr. Burkahrd Daldrup, die mir den Besuch des ergänzenden Studiengangs „Master of Drug Regulatory Affairs“ ermöglicht haben. Für die kritische Durchsicht meiner Arbeit und die vielen hilfreichen Anmerkungen danke ich meine Kolleginnen Dr. Gesine Bejeuhr, Dr. Kim Goldenstein, Dr. Maren Großmüller, Dr. Carol Huntington und Dr. Barbara Römer. Besonderer Dank gilt nicht zuletzt auch meiner Familie, vor allem meinem Mann Dr. Guido Thömmes, die meine Arbeit mit Liebe und Unterstützung begleitet hat. TABLE OF CONTENTS A1 Table of contents Table of contents......................................................................................................................... A1 Abbreviations.............................................................................................................................
    [Show full text]
  • Laws 2021, LB236, § 4
    LB236 LB236 2021 2021 LEGISLATIVE BILL 236 Approved by the Governor May 26, 2021 Introduced by Brewer, 43; Clements, 2; Erdman, 47; Slama, 1; Lindstrom, 18; Murman, 38; Halloran, 33; Hansen, B., 16; McDonnell, 5; Briese, 41; Lowe, 37; Groene, 42; Sanders, 45; Bostelman, 23; Albrecht, 17; Dorn, 30; Linehan, 39; Friesen, 34; Aguilar, 35; Gragert, 40; Kolterman, 24; Williams, 36; Brandt, 32. A BILL FOR AN ACT relating to law; to amend sections 28-1202 and 69-2436, Reissue Revised Statutes of Nebraska, and sections 28-401 and 28-405, Revised Statutes Cumulative Supplement, 2020; to redefine terms, change drug schedules, and adopt federal drug provisions under the Uniform Controlled Substances Act; to provide an exception to the offense of carrying a concealed weapon as prescribed; to define a term; to change provisions relating to renewal of a permit to carry a concealed handgun; to provide a duty for the Nebraska State Patrol; to eliminate an obsolete provision; to harmonize provisions; and to repeal the original sections. Be it enacted by the people of the State of Nebraska, Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2020, is amended to read: 28-401 As used in the Uniform Controlled Substances Act, unless the context otherwise requires: (1) Administer means to directly apply a controlled substance by injection, inhalation, ingestion, or any other means to the body of a patient or research subject; (2) Agent means an authorized person who acts on behalf of or at the direction of another person but does not include a common or contract carrier, public warehouse keeper, or employee of a carrier or warehouse keeper; (3) Administration means the Drug Enforcement Administration of the United States Department of Justice; (4) Controlled substance means a drug, biological, substance, or immediate precursor in Schedules I through V of section 28-405.
    [Show full text]
  • Coash, 27; Dubas, 34; Friend, 10; Mcgill, 26; Pirsch, 4; Rogert, 16; Wallman, 30; Giese, 17
    LB 123 LB 123 LEGISLATIVE BILL 123 Approved by the Governor February 26, 2009 Introduced by Karpisek, 32; Christensen, 44; Coash, 27; Dubas, 34; Friend, 10; McGill, 26; Pirsch, 4; Rogert, 16; Wallman, 30; Giese, 17. FOR AN ACT relating to the Uniform Controlled Substances Act; to amend section 28-405, Reissue Revised Statutes of Nebraska; to regulate Salvia divinorum or Salvinorin A; and to repeal the original section. Be it enacted by the people of the State of Nebraska, Section 1. Section 28-405, Reissue Revised Statutes of Nebraska, is amended to read: 28-405 The following are the schedules of controlled substances referred to in the Uniform Controlled Substances Act: Schedule I (a) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Acetylmethadol; (2) Allylprodine; (3) Alphacetylmethadol, except levo-alphacetylmethadol which is also known as levo-alpha-acetylmethadol, levomethadyl acetate, and LAAM; (4) Alphameprodine; (5) Alphamethadol; (6) Benzethidine; (7) Betacetylmethadol; (8) Betameprodine; (9) Betamethadol; (10) Betaprodine; (11) Clonitazene; (12) Dextromoramide; (13) Difenoxin; (14) Diampromide; (15) Diethylthiambutene; (16) Dimenoxadol; (17) Dimepheptanol; (18) Dimethylthiambutene; (19) Dioxaphetyl butyrate; (20) Dipipanone; (21) Ethylmethylthiambutene; (22) Etonitazene; (23) Etoxeridine; (24) Furethidine;
    [Show full text]
  • H 5063 State of Rhode Island
    2013 -- H 5063 ======= LC00046 ======= STATE OF RHODE ISLAND IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 2013 ____________ A N A C T RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCE ACT Introduced By: Representatives Corvese, McNamara, O'Brien, Azzinaro, and Malik Date Introduced: January 10, 2013 Referred To: House Judiciary It is enacted by the General Assembly as follows: 1 SECTION 1. Section 21-28-2.0.8 of the General Laws in Chapter 21-28 entitled 2 "Uniform Controlled Substances Act" is hereby amended to read as follows: 3 21-28-2.08. Contents of schedules. -- Schedule I 4 (a) Schedule I shall consist of the drugs and other substances, by whatever official name, 5 common or usual name, chemical name, or brand name designated, listed in this section. 6 (b) Opiates. - Unless specifically excepted or unless listed in another schedule, any of 7 the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and 8 ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the 9 specific chemical designation: 10 (1) Acetylmethadol 11 (2) Allylprodine 12 (3) Alphacetylmethadol 13 (4) Alphameprodine 14 (5) Alphamethadol 15 (6) Benzethidine 16 (7) Betacetylmethadol 17 (8) Betameprodine 18 (9) Betamethadol 19 (10) Betaprodine 1 (11) Clonitazene 2 (12) Dextromoramide 3 (13) Difenoxin 4 (14) Diampromide 5 (15) Diethylthiambutene 6 (16) Dimenoxadol 7 (17) Dimepheptanol 8 (18) Dimethylthiambutene 9 (19) Dioxaphetyl butyrate 10 (20) Dipipanone 11 (21) Ethylmethylthiambutene
    [Show full text]
  • View Document
    Connecticut eRegulations System — Tracking Number ER2018-038 — Posted 11/9/2018 Secretary of the State File Number 6283 Emergency Regulation of the Department of Consumer Protection Concerning Federally Approved Medications Containing Marijuana Products Emergency regulations adopted after October 1, 2016, become effective upon posting to the Connecticut eRegulations System. Posted to the Connecticut eRegulations System on November 9, 2018 EFFECTIVE DATE November 9, 2018 Approved by the Office of the Governor on October 19, 2018 Approved by the Legislation Regulation Review Committee on November 7, 2018 Electronic copy with agency head certification statement electronically submitted to and received by the Office of the Secretary of the State on November 9, 2018 Connecticut eRegulations System — Tracking Number ER2018-038 — Posted 11/9/2018 Connecticut eRegulations System — Tracking Number ER2018-038 — Posted 11/9/2018 Page 1 of 4 State of Connecticut Regulation of Department of Consumer Protection Concerning Federally Approved Medications Containing Marijuana Products Section 1. Section 21a-243-8 of the Regulations of Connecticut State Agencies is amended to read as follows: Sec. 21a-243-8. Controlled substances in schedule II The controlled substances listed in this regulation are included by whatever official, common, usual, chemical, or trade name designation in Schedule II: (a) Any of the following substances, except those narcotic drugs listed in other schedules, whether produced directly or indirectly by extraction from substances
    [Show full text]